Evidence map›Paper›PMID 42656273›Full record

ArticleFrontiers in cellular and infection microbiology2026

Integrative genomic and clinical analysis of carbapenem-resistant and susceptible

Mengling Liu, Zhiyong Wu, Jieyu Mao, Shuo Zhang, Sheng Xu, Jinwen Min, Wenjing Yu, Haizhou Liu, Yangbo Hu, Xiaojun Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mengling Liu *Department of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
Zhiyong Wu *Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Jieyu MaoDepartment of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
Shuo ZhangDepartment of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
Sheng XuDepartment of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
Jinwen MinDepartment of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
Wenjing YuKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Haizhou LiuKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Yangbo HuKey Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Xiaojun WuDepartment of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Carbapenem-resistant Methods: A total of 40 CRKP and 42 carbapenem-susceptible Results: Clinical analysis identified a Charlson comorbidity index > 3 and respiratory tract infections as independent risk factors for CRKP infection. Genomic comparisons revealed that CRKP strains harbored more resistance and virulence genes than CSKP strains, with ST11 being the dominant CRKP clone that frequently carried the Conclusions: CCI >3 and respiratory tract infection were independently associated with CRKP infection. ST11-

Indexed as

Carbapenem-Resistant EnterobacteriaceaeCarbapenemsKlebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial Agentsbeta-LactamasesChinaGenome, BacterialGenomicsHumansMicrobial Sensitivity TestsPhylogenyPlasmidsPolymorphism, Single NucleotideRisk FactorsTertiary Care CentersAnti-Bacterial Agentsbeta-LactamasesCarbapenemsVirulence Factorscarbapenem-resistant Klebsiella pneumoniaecarbapenem-susceptible Klebsiella pneumoniaeclinical risk factorscomparative genomicspan-genome

Identifiers

PMID42656273
PMCPMC13506390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.